about
Determination of PCR efficiency in chelex-100 purified clinical samples and comparison of real-time quantitative PCR and conventional PCR for detection of Chlamydia pneumoniaeRole of Nucleotide-binding and Oligomerization Domain 2 Protein (NOD2) in the Development of AtherosclerosisTherapeutic targeting of NOD1 receptorsNovel Chlamydia pneumoniae vaccine candidates confirmed by Th1-enhanced genetic immunizationImpact of monocytic cells on recovery of uncultivable bacteria from atherosclerotic lesions.The Chlamydia outer membrane protein OmcB is required for adhesion and exhibits biovar-specific differences in glycosaminoglycan binding.Identification and characterization of Chlamydia pneumoniae-specific proteins that activate tumor necrosis factor alpha production in RAW 264.7 murine macrophages.Inverse association between Chlamydia pneumoniae respiratory tract infection and initiation of asthma or allergic rhinitis in children.Single-run, parallel detection of DNA from three pneumonia-producing bacteria by real-time polymerase chain reaction.Promoter polymorphism of the gene for CD14 receptor is not associated with sub-clinical carotid atherosclerosis in a community population.Proinflammatory cytokines, antibodies to Chlamydia pneumoniae and age-associated diseases in Danish centenarians: is there a link?In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations--a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases.Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages.Characterization of antiapoptotic activities of Chlamydia pneumoniae in human cells.
P2860
Q24798213-89286DAB-0138-4336-A1E1-B5226670A51EQ26777991-BAE9C940-71F3-467E-AC96-65A0320186C0Q28676201-9E1DFF57-9136-49E4-8D86-367E9E904EC0Q33653680-553BA47F-D22B-4D9E-A26C-5AF9398C4D5AQ35097901-A79CE7FB-BAC1-4F6E-ACFE-320F0A768BEBQ36437361-2FE5964F-1645-40CF-8D18-E236656DDE30Q36539539-733F0A64-E403-4B3B-8EF2-328CB67F4671Q37865216-829DF84F-6790-4A7D-8A27-F1D86FC01D76Q37865603-5D73214B-A87E-426E-9088-C7A11C04302DQ37866679-8649F128-3229-4355-832E-E527802BAE25Q37871352-11A8AB76-F7A6-48B4-82A9-472698561F40Q37872047-F81E7548-D6BE-4236-A1E7-B42031E4DCD7Q37872148-8E2745AB-A6CF-4A4E-BB77-43354AE377FCQ37873267-FB778EB8-76A5-46F2-A244-B4D7C58C0D3D
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Chlamydia pneumoniae in atherosclerosis.
@ast
Chlamydia pneumoniae in atherosclerosis.
@en
type
label
Chlamydia pneumoniae in atherosclerosis.
@ast
Chlamydia pneumoniae in atherosclerosis.
@en
prefLabel
Chlamydia pneumoniae in atherosclerosis.
@ast
Chlamydia pneumoniae in atherosclerosis.
@en
P2860
P1476
Chlamydia pneumoniae in atherosclerosis.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2796.2000.00659.X
P407
P577
2000-03-01T00:00:00Z